[89Zr]Zr-ImmunoPET to evaluate the efficacy of cleavable linkers in antibody drug conjugates

被引:0
|
作者
Garcia, M. Dominguez [1 ]
Raheem, S. J. [1 ]
Sharpe, J. C. [1 ]
Toosi, B. M. [1 ]
Phenix, C. P. [1 ]
Price, E. W. [1 ]
机构
[1] Univ Saskatchewan, Saskatoon, SK, Canada
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP-882
引用
收藏
页码:S283 / S283
页数:1
相关论文
共 50 条
  • [31] Optimisation of scan duration and image quality in oncological 89Zr immunoPET imaging using the Biograph Vision PET/CT
    van Sluis, Joyce
    Boellaard, Ronald
    Dierckx, Rudi A. J. O.
    van Esch, Evelien L. M.
    Croes, Demi A.
    de Ruijter, Laura Kist
    van de Donk, Pim P.
    de Vries, Elisabeth G. E.
    Noordzij, Walter
    Brouwers, Adrienne H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (08) : 2258 - 2270
  • [32] Optimisation of scan duration and image quality in oncological 89Zr immunoPET imaging using the Biograph Vision PET/CT
    Joyce van Sluis
    Ronald Boellaard
    Rudi A. J. O. Dierckx
    Evelien L. M. van Esch
    Demi A. Croes
    Laura Kist de Ruijter
    Pim P. van de Donk
    Elisabeth G. E. de Vries
    Walter Noordzij
    Adrienne H. Brouwers
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 2258 - 2270
  • [33] Protease-Cleavable Linkers Modulate the Anticancer Activity of Noninternalizing Antibody-Drug Conjugates
    Dal Corso, Alberto
    Cazzamalli, Samuele
    Gebleux, Remy
    Mattarella, Martin
    Neria, Dario
    BIOCONJUGATE CHEMISTRY, 2017, 28 (07) : 1826 - 1833
  • [34] 89Zr-MSTP2109A, A Novel Antibody Based Radiotracer to Evaluate and Guide the Clinical Translation of Antibody-Drug Conjugates Targeting STEAP1
    Spratt, D. E.
    Doran, M. G.
    Wongvipat, J.
    Lewis, J. S.
    Evans, M. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S791 - S791
  • [35] In Vivo Characterization of Platinum(II)-Based Linker Technology for the Development of Antibody-Drug Conjugates: Taking Advantage of Dual Labeling with 195mPt and 89Zr
    Muns, Joey A.
    Montserrat, Veronica
    Houthoff, Hendrik-Jan
    Codee-van der Schilden, Karlijn
    Zwaagstra, Oene
    Sijbrandi, Niels J.
    Merkul, Eugen
    van Dongen, Guus A. M. S.
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (07) : 1146 - 1151
  • [36] Development of a [89Zr]Zr-labeled Human Antibody using a Novel Phage-displayed Human scFv Library
    Singh, Abhay K.
    Lewis, Calvin D.
    Boas, Cristian A. W. V.
    Diebolder, Philipp
    Jethva, Prashant N.
    Rhee, Aaron
    Song, Jong Hee
    Goo, Young Ah
    Li, Shunqian
    Nickels, Michael L.
    Liu, Yongjian
    Rogers, Buck E.
    Kapoor, Vaishali
    Hallahan, Dennis E.
    CLINICAL CANCER RESEARCH, 2024, 30 (07) : 1293 - 1306
  • [37] Novel Bifunctional Cyclic Chelator for 89Zr Labeling-Radiolabeling and Targeting Properties of RGD Conjugates
    Zhai, Chuangyan
    Summer, Dominik
    Rangger, Christine
    Franssen, Gerben M.
    Laverman, Peter
    Haas, Hubertus
    Petrik, Milos
    Haubner, Roland
    Decristoforo, Clemens
    MOLECULAR PHARMACEUTICS, 2015, 12 (06) : 2142 - 2150
  • [38] Evaluating immune checkpoint blockade treatment efficacy via [89Zr]-CD4 and [89Zr]-CD8 PET imaging in breast cancer mouse models
    Lu, Yun
    Houson, Hailey
    Mascioni, Alessandro
    Jia, Fang
    Song, Patrick N.
    Napier, Tiara
    Mansur, Amer M.
    Gallegos, Carlos A.
    Larimer, Benjamin M.
    Lapi, Suzanne E.
    Sorace, Anna G.
    CANCER RESEARCH, 2022, 82 (12)
  • [39] Construction of [89Zr]Zr-Labeled HuL13 for ImmunoPET Imaging of LAG-3 Checkpoint Expression on Tumor-Infiltrating T Cells
    Ding, Lixin
    Wang, Feng
    Wang, Zilei
    Pan, Yongxiang
    Liu, Teli
    Cheng, Liansheng
    Liu, Wenting
    Ding, Kuke
    Zhu, Hua
    Yang, Zhi
    MOLECULAR PHARMACEUTICS, 2024, 21 (08) : 3992 - 4003
  • [40] Radiation dosimetry of 89Zr labeled antibody estimated using the MIRD method and MCNP code
    Yazdi, Saeideh Izadi
    Sadeghi, Mahdi
    Saeedzadeh, Elham
    Jalilifar, Mostafa
    NUCLEAR ENGINEERING AND TECHNOLOGY, 2023, 55 (04) : 1265 - 1268